Form 4: Teladoc Director David B. Snow Jr. Reports Stock Vesting
Statement of Changes in Beneficial Ownership
Director David B. Snow Jr. acquired 28,986 shares of Teladoc Health common stock via restricted stock unit vesting and was granted 30,441 new units.
Summary
- Director David B. Snow Jr. exercised restricted stock units (RSUs) to acquire 28,986 shares of Teladoc Health common stock on May 20, 2026.
- The reporting person received a new grant of 30,441 restricted stock units on May 21, 2026.
- Following these transactions, the director holds 113,032 shares directly and 52,000 shares indirectly through an irrevocable trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding director compensation, which carries no material impact on the company's outlook.
Positives
- Director maintains significant skin in the game with a total beneficial ownership of 165,032 shares.
Negatives
- None identified; this is a standard equity compensation disclosure.
Risks
- None identified; this is a standard equity compensation disclosure.
Future Outlook
The newly granted 30,441 restricted stock units are scheduled to vest in full on the earlier of May 21, 2027, or the day preceding the 2027 annual meeting of stockholders.
Industry Context
StockSavvy.ai notes that routine equity compensation disclosures for directors are standard practice in the healthcare technology sector and do not typically signal changes in corporate strategy or financial health.
Comparison to Industry Standards
- The equity compensation structure aligns with standard corporate governance practices for publicly traded companies in the U.S. healthcare sector.
Related Party Transactions
- The reporting person's spouse serves as trustee for the David B. Snow, Jr. Irrevocable Trust, which holds 52,000 shares.
Stakeholder Impact
- Minimal impact on shareholders as these transactions represent standard director compensation.
Next Steps
- Vesting of 30,441 restricted stock units on or before May 21, 2027.
Key Dates
| Date | Description |
|---|---|
| 2012-12-12 | Date of the David B. Snow, Jr. Irrevocable Trust. |
| 2025-05-22 | Original grant date of the 28,986 RSUs that vested. |
| 2026-05-20 | Vesting date of 28,986 RSUs and transaction date for acquisition. |
| 2026-05-21 | Grant date of 30,441 new RSUs and filing date. |
Keywords
Teladoc Health, TDOC, Form 4, Insider Trading, Director Compensation, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.